Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001144204-16-110012
Filing Date
2016-06-27
Accepted
2016-06-27 16:28:27
Documents
128
Reference 429
333-195265

Document Format Files

Seq Description Document Type Size
1 S-1 v442847_s1.htm S-1 1810624
2 EXHIBIT 5.1 v442847_ex5-1.htm EX-5.1 11478
3 EXHIBIT 21 v442847_ex21.htm EX-21 1375
4 EXHIBIT 23.1 v442847_ex23-1.htm EX-23.1 3659
5 EXHIBIT 23.2 v442847_ex23-2.htm EX-23.2 3480
131 filename131.htm CORRESP 4843
  Complete submission text file 0001144204-16-110012.txt   10990689

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT eltp-20160331.xml EX-101.INS 2761735
8 XBRL TAXONOMY EXTENSION SCHEMA eltp-20160331.xsd EX-101.SCH 98269
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE eltp-20160331_cal.xml EX-101.CAL 62333
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE eltp-20160331_def.xml EX-101.DEF 496396
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE eltp-20160331_lab.xml EX-101.LAB 571581
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eltp-20160331_pre.xml EX-101.PRE 596471
Mailing Address 165 LUDLOW AVENUE NORTHVALE NJ 07647
Business Address 165 LUDLOW AVENUE NORTHVALE NJ 07647 2017502646
ELITE PHARMACEUTICALS INC /NV/ (Filer) CIK: 0001053369 (see all company filings)

EIN.: 223542636 | State of Incorp.: NV | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-212266 | Film No.: 161733672
SIC: 2834 Pharmaceutical Preparations